Filter by: patients
Home > Community Treatment Reports and Side Effects > Valganciclovir Treatment Report
What is Valganciclovir?

Valganciclovir is an antiviral agent used to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome, and prevention of CMV disease in high-risk patients undergoing kidney, heart, or kidney/pancreas transplantation.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Prevent infection 36 12 Efficacy_major Efficacy_moderate Efficacy_cant_tell
Cytomegalovirus 10 4 Efficacy_major Efficacy_cant_tell
Cytomegalovirus (CMV) retinitis 6 3 Efficacy_major Efficacy_none Efficacy_cant_tell
Kidney Transplant 5 2 Efficacy_major Efficacy_moderate
donor positive for CMV 5 3 Efficacy_major Efficacy_cant_tell
Chronic Fatigue Syndrome 3 0

See all 69 patients currently taking Valganciclovir

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 7
None
 17

Commonly reported side effects, conditions, and hospitalizations associated with Valganciclovir

Fatigue 1
Low white blood cell count (leukopenia) 1
Diarrhea chronic 1

Reported Dosages

  450mg as needed daily 450 mg every other week 450 mg m,w,f 450 mg daily 900 mg daily 1,800 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 30 Number of Patients: 30 32 Number of Patients: 32 4 Number of Patients: 4  

Reported Stop Reasons

Why Patients Stopped Taking Valganciclovir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 21   Course of treatment ended: 60%
Doctor's advice 15   Doctor's advice: 43%
Other 2   Other: 6%
Did not seem to work 1   Did not seem to work: 3%
Expense 1   Expense: 3%

See all 33 patients who’ve stopped taking Valganciclovir

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Valganciclovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Valganciclovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Valganciclovir

Always
 22 92%
Usually
 0 0%
Sometimes
 0 0%
Never
 2 8%

Burden

Difficulty being on treatment

Burden of Valganciclovir

Very
 0 0%
Somewhat
 1 4%
A little
 1 4%
Not at all
 22 92%

Cost

Paid out of pocket

Cost of Valganciclovir

$200+
 0 0%
$100-199
 0 0%
$50-99
 3 21%
$25-49
 2 14%
< $25
 9 64%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.